Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Seizure-induced LIN28A disrupts pattern separation via aberrant hippocampal neurogenesis
In-Young Choi, Jung-Ho Cha, Seong Yun Kim, Jenny Hsieh, Kyung-Ok Cho
In-Young Choi, Jung-Ho Cha, Seong Yun Kim, Jenny Hsieh, Kyung-Ok Cho
View: Text | PDF
Research Article Neuroscience Stem cells

Seizure-induced LIN28A disrupts pattern separation via aberrant hippocampal neurogenesis

  • Text
  • PDF
Abstract

Prolonged seizures can disrupt stem cell behavior in the adult hippocampus, an important brain structure for spatial memory. Here, using a mouse model of pilocarpine-induced status epilepticus (SE), we characterized spatiotemporal expression of Lin28a mRNA and proteins after SE. Unlike Lin28a transcripts, induction of LIN28A protein after SE was detected mainly in the subgranular zone, where immunoreactivity was found in progenitors, neuroblasts, and immature and mature granule neurons. To investigate roles of LIN28A in epilepsy, we generated Nestin-Cre:Lin28aloxP/loxP (conditional KO [cKO]) and Nestin-Cre:Lin28a+/+ (WT) mice to block LIN28A upregulation in all neuronal lineages after acute seizure. Adult-generated neuron- and hippocampus-associated cognitive impairments were absent in epileptic LIN28A-cKO mice, as evaluated by pattern separation and contextual fear conditioning tests, respectively, while sham-manipulated WT and cKO animals showed comparable memory function. Moreover, numbers of hilar PROX1-expressing ectopic granule cells (EGCs), together with PROX1+/NEUN+ mature EGCs, were significantly reduced in epileptic cKO mice. Transcriptomics analysis and IHC validation at 3 days after pilocarpine administration provided potential LIN28A downstream targets such as serotonin receptor 4. Collectively, our findings indicate that LIN28A is a potentially novel target for regulation of newborn neuron-associated memory dysfunction in epilepsy by modulating seizure-induced aberrant neurogenesis.

Authors

In-Young Choi, Jung-Ho Cha, Seong Yun Kim, Jenny Hsieh, Kyung-Ok Cho

×

Figure 3

Cellular phenotypes of LIN28A expression in the subgranular zone (SGZ) of the dentate gyrus after pilocarpine-induced status epilepticus (SE).

Options: View larger image (or click on image) Download as PowerPoint
Cellular phenotypes of LIN28A expression in the subgranular zone (SGZ) o...
(A) Experimental timeline. (B) Double immunofluorescence of LIN28A and stage-specific markers of hippocampal neurogenesis at 3 d after SE showed that LIN28A immunoreactivity colocalized with Nestin, DCX, calretinin, and NEUN, indicating type 2 progenitors, neuroblasts, immature, and mature granule neurons. However, LIN28A expression in the SGZ did not colocalize with GFAP, suggesting that type 1 neural stem cells did not express LIN28A. Scale bar: 20 μm. (C) A graph showing the phenotypic analysis of LIN28A-expressing cells after acute seizure. Welch’s ANOVA was performed, followed by 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli post hoc test. P = 0.001, W(4.000, 7.210) = 89.650. GFAP+/LIN28+ (n = 4), Nestin+/LIN28+ (n = 4), DCX+/LIN28+ (n = 5), calretinin+/LIN28+ (n = 5), NEUN+/LIN28+ (n = 4). Data are presented as mean ± SEM. *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts